BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gluba-Brzózka A, Rysz J, Ławiński J, Franczyk B. Renal Cell Cancer and Obesity. Int J Mol Sci 2022;23:3404. [PMID: 35328822 DOI: 10.3390/ijms23063404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chinapayan SM, Kuppusamy S, Yap NY, Perumal K, Gobe G, Rajandram R. Potential Value of Visfatin, Omentin-1, Nesfatin-1 and Apelin in Renal Cell Carcinoma (RCC): A Systematic Review and Meta-Analysis. Diagnostics (Basel) 2022;12. [PMID: 36553076 DOI: 10.3390/diagnostics12123069] [Reference Citation Analysis]
2 Allegrini S, Garcia-Gil M, Pesi R, Camici M, Tozzi MG. The Good, the Bad and the New about Uric Acid in Cancer. Cancers (Basel) 2022;14:4959. [PMID: 36230882 DOI: 10.3390/cancers14194959] [Reference Citation Analysis]
3 Du W, Guo K, Jin H, Sun L, Ruan S, Song Q. Association Between Metabolic Syndrome and Risk of Renal Cell Cancer: A Meta-Analysis. Front Oncol 2022;12:928619. [DOI: 10.3389/fonc.2022.928619] [Reference Citation Analysis]